Antimicrobial combination effects against multidrug-resistant and strains: A cross-sectional study.

BACKGROUND AND AIMS

Emergence of multidrug resistance in non-fermenting Gram-negative bacilli is a threat to public health. Combination therapy is a strategy for the treatment of antibiotic-resistant infections.

METHODS

In this cross-sectional study, a total of 63 nonduplicate clinical isolates of and  were collected from various specimens. Identification of bacterial isolates was performed by phenotypic and molecular tests. Antibiotic susceptibility patterns and detection of β-lactamase genes were determined using the broth microdilution and polymerase chain reaction (PCR) techniques, respectively. Then, the combined effects analysis was determined by the checkerboard method. Based on the status of resistance to carbapenems (imipenem and meropenem), 25 isolates of each genus were selected for further investigation.

RESULTS

For , , and genes were positive in 21 (84%), 17 (68%), and 11 (44%) of isolates, respectively. In isolates, was the most common gene (44%) and other genes including , , and were found in nine (36%), six (24%), and three (12%) isolates, respectively. Meropenem (MER)-tigecycline (TIG) had a significant synergistic effect against 20 (80%) ( value < 0.001). This combination was also efficient against 5 (20%) isolates. Moreover, the other combination, tigecycline-amikacin (TIG-AMK) was effective against 10 (40%) isolates. The combination of colistin (COL) and MER showed a significant synergistic effect against 21 (84%) ( value < 0.001) and 17 (68%) isolates ( value < 0.001).

CONCLUSION

The MER-TIG and COL-MER combinations are promising options against resistant bacteria. Our study could be helpful for the development of a new treatment recommendation.